Growth Metrics

Q32 Bio (QTTB) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for Q32 Bio (QTTB) over the last 4 years, with Q3 2025 value amounting to $21.2 million.

  • Q32 Bio's Total Non-Current Liabilities fell 3205.11% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year decrease of 3205.11%. This contributed to the annual value of $31.7 million for FY2024, which is 2609.55% down from last year.
  • Per Q32 Bio's latest filing, its Total Non-Current Liabilities stood at $21.2 million for Q3 2025, which was down 3205.11% from $23.4 million recorded in Q2 2025.
  • In the past 5 years, Q32 Bio's Total Non-Current Liabilities registered a high of $48.5 million during Q1 2024, and its lowest value of $21.2 million during Q3 2025.
  • For the 4-year period, Q32 Bio's Total Non-Current Liabilities averaged around $33.4 million, with its median value being $31.7 million (2024).
  • In the last 5 years, Q32 Bio's Total Non-Current Liabilities skyrocketed by 1356.65% in 2023 and then plummeted by 4203.54% in 2025.
  • Quarter analysis of 4 years shows Q32 Bio's Total Non-Current Liabilities stood at $37.7 million in 2022, then rose by 13.57% to $42.8 million in 2023, then decreased by 26.1% to $31.7 million in 2024, then tumbled by 32.93% to $21.2 million in 2025.
  • Its last three reported values are $21.2 million in Q3 2025, $23.4 million for Q2 2025, and $28.1 million during Q1 2025.